What is Actuate Therapeutics, Inc. Common stock's Market Cap?

Actuate Therapeutics, Inc. Common stock's Market Cap is $32.9M, based on as-reported figures from SEC (XBRL) filings.

What is Actuate Therapeutics, Inc. Common stock's Enterprise Value?

Actuate Therapeutics, Inc. Common stock's Enterprise Value is $28.5M, based on as-reported figures from SEC (XBRL) filings.

What is Actuate Therapeutics, Inc. Common stock's Net Income (TTM)?

Actuate Therapeutics, Inc. Common stock's Net Income (TTM) is -$20.5M, based on as-reported figures from SEC (XBRL) filings.

What is Actuate Therapeutics, Inc. Common stock's Diluted EPS (TTM)?

Actuate Therapeutics, Inc. Common stock's Diluted EPS (TTM) is -0.85, based on as-reported figures from SEC (XBRL) filings.

What is Actuate Therapeutics, Inc. Common stock's Net Debt?

Actuate Therapeutics, Inc. Common stock's Net Debt is -$4.4M, based on as-reported figures from SEC (XBRL) filings.

Actuate Therapeutics, Inc. Common stock (ACTU) Financial Statements

Actuate Therapeutics, Inc. Common stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00NK7LK12

XNAS · usd

1.37▼ 0.11 (-7.43%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.48

Day's Range1.33 – 1.48

52-Week Range0.90 – 8.55

Volume209.8K

Avg Volume394.8K

Share Statistics

Shares Outstanding

Employees12

ExchangeXNAS

Listed2024-08-13

Share count as of August 13, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Actuate Therapeutics, Inc. Common stock (ACTU)

What is Actuate Therapeutics, Inc. Common stock's Market Cap?: Actuate Therapeutics, Inc. Common stock's Market Cap is $32.9M, based on as-reported figures from SEC (XBRL) filings.
What is Actuate Therapeutics, Inc. Common stock's Enterprise Value?: Actuate Therapeutics, Inc. Common stock's Enterprise Value is $28.5M, based on as-reported figures from SEC (XBRL) filings.
What is Actuate Therapeutics, Inc. Common stock's Net Income (TTM)?: Actuate Therapeutics, Inc. Common stock's Net Income (TTM) is -$20.5M, based on as-reported figures from SEC (XBRL) filings.
What is Actuate Therapeutics, Inc. Common stock's Diluted EPS (TTM)?: Actuate Therapeutics, Inc. Common stock's Diluted EPS (TTM) is -0.85, based on as-reported figures from SEC (XBRL) filings.
What is Actuate Therapeutics, Inc. Common stock's Net Debt?: Actuate Therapeutics, Inc. Common stock's Net Debt is -$4.4M, based on as-reported figures from SEC (XBRL) filings.